newsfilter
← Latest News
Business Wire·

AVROBIO Reports First Quarter 2022 Financial Results and Provides Business Update

Phase 1/2 collaborator-sponsored1 clinical trial in cystinosis fully enrolled New interim cystinosis clinical data to be presented at the 25th annual meeting of the American Society of Gene and Cell Therapy (ASGCT) Multiple regulatory interactions